Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial dysfunction in osteoarthritis.

Francisco J Blanco1, Maria J López-Armada, Emilia Maneiro

  • 1Laboratory of Investigation, Rheumatology Division, Complejo Hospitalario Universitario Juan Canalejo, C/Xubias, 84, 15006 A Coruña, Spain. francisco_blanco@canalejo.org

Mitochondrion
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between progression of knee osteoarthritis pathology and gait changes over two years: Data from the IMI-APPROACH cohort.

Osteoarthritis imaging·2026
Same author

Impact of quantified knee positioning on the measurement of minimal joint space width using statistical shape models: A cross-sectional and longitudinal analysis in the IMI-APPROACH.

Osteoarthritis imaging·2026
Same author

Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial.

Nature medicine·2026
Same author

Progression of bone and joint space deformity in patients with mild knee osteoarthritis: Data from the IMI-APPROACH cohort.

Osteoarthritis and cartilage open·2026
Same author

Redox-Related Genetic and Biological Ageing Signals in Rapid Pain Progression of Knee Osteoarthritis: A Hypothesis-Generating Analysis in the Osteoarthritis Initiative.

Antioxidants (Basel, Switzerland)·2026
Same journal

miR-205-5p accelerates lung fibroblast senescence in IPF patients via mediation of mitochondrial dynamics.

Mitochondrion·2026
Same journal

A neuronal model of mtDNA disease reveals an ineffective reprogramming of the electron transfer chain during neuronal maturation.

Mitochondrion·2026
Same journal

ATPIF1, the rheostat in mitochondrial bioenergetics and dysfunction in diseases.

Mitochondrion·2026
Same journal

Spatholobi caulis and Epicatechin amplify erythropoiesis through mitochondrial translocation of AKT and enhanced oxidative phosphorylation.

Mitochondrion·2026
Same journal

DNM1L depletion leads to accelerated heteroplasmy shifting of m.10191C allele through ATG7-dependent pathways.

Mitochondrion·2026
Same journal

Energy beats: Daily and circadian rhythms in mitochondrial biology.

Mitochondrion·2026
See all related articles

Mitochondrial dysfunction in osteoarthritis (OA) involves reduced respiratory chain activity and membrane potential, contributing to chondrocyte apoptosis and cartilage calcification. Targeting mitochondrial function may offer new OA treatment strategies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) involves progressive cartilage degradation, characterized by chondrocyte dysfunction, matrix loss, and calcification.
  • Chondrocyte energy metabolism, particularly mitochondrial function, is crucial for maintaining cartilage homeostasis and is implicated in OA pathogenesis.

Purpose of the Study:

  • To investigate the role of mitochondrial respiratory chain (MRC) activity and mitochondrial membrane potential (ΔΨm) in OA chondrocytes.
  • To explore the relationship between mitochondrial dysfunction, chondrocyte apoptosis, and matrix calcification in OA.
  • To examine the impact of nitric oxide (NO) and aging on chondrocyte mitochondrial function.

Main Methods:

  • Analysis of MRC complex activity (e.g., complexes II and III) and citrate synthase (CS) activity in OA chondrocytes.

Related Experiment Videos

  • Measurement of mitochondrial membrane potential (ΔΨm) using JC-1 fluorescent probe.
  • Assessment of apoptotic markers (Bcl-2, caspase-3) and nitric oxide synthase (NOS) expression.
  • Inhibition of MRC complexes (e.g., complex IV, I) to study effects on chondrocyte survival and matrix metabolism.

    • Main Results:

    • OA chondrocytes exhibit decreased MRC complexes II and III activity but increased mitochondrial mass (CS activity) and reduced ΔΨm.
    • Elevated Bcl-2 and caspase-3 expression correlates with chondrocyte apoptosis and OA severity.
    • Nitric oxide (NO) reduces chondrocyte survival, decreases ΔΨm, and modulates apoptotic and anti-apoptotic gene expression.
    • Inhibition of MRC complexes exacerbates matrix calcification and induces apoptosis, mimicking some OA features.

    Conclusions:

    • Mitochondrial dysfunction, including impaired MRC activity and reduced ΔΨm, is a key feature of OA chondrocytes.
    • NO contributes to OA pathogenesis by inducing chondrocyte apoptosis and altering mitochondrial function.
    • Mitochondrial respiration plays a critical role in regulating matrix calcification in chondrocytes.
    • Targeting mitochondrial pathways presents a potential therapeutic strategy for OA.